| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $93,554,718 ) (Continued on the next page) |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01DA061678 | Sex differences in modulating HIV/SIV reservoirs in the context of opioids | 000 | 1 | NIH | 8/29/2024 | $690,750 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | F32AA032170 | Negative reinforcement in early abstinence from an alcohol use disorder | 000 | 1 | NIH | 8/29/2024 | $79,456 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R34CA287719 | Parents helping Parents for Youth Vaping Cessation (PhP-VX) | 000 | 1 | NIH | 8/28/2024 | $247,433 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AI168315 | Proteostasis in Plasmodium falciparum artemisinin resistance | 001 | 1 | NIH | 5/31/2024 | $74,626 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AI168315 | Proteostasis in Plasmodium falciparum artemisinin resistance | 000 | 1 | NIH | 1/11/2024 | $671,642 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AR082148 | Effective local delivery of bone anabolic agent to accelerate the healing of delayed fracture union | 001 | 2 | NIH | 5/29/2024 | $30,869 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AR082148 | Effective local delivery of bone anabolic agent to accelerate the healing of delayed fracture union | 000 | 2 | NIH | 1/10/2024 | $396,894 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | F30ES036063 | Targeting the ACOD1 immunometabolic pathway of lung myeloid cells to reduce environmental exposure-induced lung disease | 002 | 1 | NIH | 7/19/2024 | $1,280 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | F30ES036063 | Targeting the ACOD1 immunometabolic pathway of lung myeloid cells to reduce environmental exposure-induced lung disease | 001 | 1 | NIH | 1/8/2024 | $0 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | F30ES036063 | Targeting the ACOD1 immunometabolic pathway of lung myeloid cells to reduce environmental exposure-induced lung disease | 000 | 1 | NIH | 1/8/2024 | $36,447 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | P50AA030407 | Alcohol Center Of Research -- Nebraska (ACORN) | 001 | 2 | NIH | 8/23/2024 | $0 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | P50AA030407 | Alcohol Center Of Research -- Nebraska (ACORN) | 000 | 2 | NIH | 1/23/2024 | $1,588,725 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | F30AG084348 | Measuring neurodevelopmental effects of genetic risk for Alzheimer's disease via cross-sectional study of brain, cognitive, and physical fitness variables in periadolescent children | 000 | 1 | NIH | 5/24/2024 | $37,727 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA266759 | Nanomedicine of Hedgehog and AKT/ERK Dual Inhibitors for Pancreatic Cancer | 001 | 3 | NIH | 4/16/2024 | $22,106 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA266759 | Nanomedicine of Hedgehog and AKT/ERK Dual Inhibitors for Pancreatic Cancer | 000 | 3 | NIH | 1/3/2024 | $397,900 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL155439 | GATA Factor Mechanisms in Erythroid Regeneration | 000 | 4 | NIH | 12/18/2023 | $383,750 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R21NS139920 | Neurological Disorders in HIV-1 Infection | 000 | 1 | NIH | 8/6/2024 | $230,250 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | F30AI186408 | Nitrogen Metabolism of Staphylococcus aureus | 000 | 1 | NIH | 8/7/2024 | $45,574 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | NU01DD000042 | Partnerships for Urban MCH to Advance Health Equity through FIMR and PPOR (Component A, Strategies 1-6) and an Emergency Response Consortium (Component B, Strategy 1) | 00 | 2 | CDC | 8/26/2024 | $562,000 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01MH132517 | PREVENTING ALZHEIMER’S DISEASE-LIKE BRAIN PATHOLOGY IN HIV INFECTION BY TARGETING CCR5 | 001 | 2 | NIH | 8/14/2024 | $69,075 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01MH132517 | PREVENTING ALZHEIMER’S DISEASE-LIKE BRAIN PATHOLOGY IN HIV INFECTION BY TARGETING CCR5 | 000 | 2 | NIH | 1/19/2024 | $621,673 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R37CA293214 | Assessment of strategies for targeting transcriptional co-activators in colorectal cancer | 000 | 1 | NIH | 8/7/2024 | $439,367 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R21AA031928 | Non-ISGylated HIV proteins are sorted to hepatic exosomes to activate liver fibrosi | 000 | 1 | NIH | 8/8/2024 | $220,656 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | T5949625 | Advanced Nursing Education- Nurse Practitioner Residency Fellowship Program | 00 | 2 | HRSA | 7/15/2024 | $674,924 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01DK119337 | Mechanisms of iron-mediated renal injury in lupus nephritis | 001 | 5 | NIH | 5/6/2024 | $20,130 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01DK119337 | Mechanisms of iron-mediated renal injury in lupus nephritis | 000 | 5 | NIH | 1/29/2024 | $301,950 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA260749 | UPR Activators for Cancer Therapy | 001 | 3 | NIH | 4/16/2024 | $17,557 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA260749 | UPR Activators for Cancer Therapy | 000 | 3 | NIH | 1/9/2024 | $316,018 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL156952 | Defective Zn Homeostasis impairs host defense against pneumococcal pneumonia | 001 | 3 | NIH | 6/26/2024 | $38,375 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL156952 | Defective Zn Homeostasis impairs host defense against pneumococcal pneumonia | 000 | 3 | NIH | 11/6/2023 | $345,375 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL160820 | Skeletal Muscle Nrf2: Exercise-Induced Cardiovascular Protection | 001 | 3 | NIH | 6/13/2024 | $41,479 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL160820 | Skeletal Muscle Nrf2: Exercise-Induced Cardiovascular Protection | 000 | 3 | NIH | 12/5/2023 | $466,635 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R13AI183714 | Annual meeting of the American Society for Rickettsiology | 000 | 1 | NIH | 7/5/2024 | $11,000 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R21CA280020 | Targeting FGFR4 to overcome chemoresistance in ovarian cancer | 001 | 1 | NIH | 7/3/2024 | $0 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01GM141232 | Regulation of SPRTN protease and SPRTN-mediated DNA-Protein Crosslink Repair | 001 | 3 | NIH | 7/25/2024 | $31,467 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01GM141232 | Regulation of SPRTN protease and SPRTN-mediated DNA-Protein Crosslink Repair | 000 | 3 | NIH | 3/20/2024 | $283,208 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01DA054535 | Impact of drugs of abuse on HIV brain reservoirs and HAND in humanized microglia mice | 000 | 4 | NIH | 5/1/2024 | $538,785 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01DK129311 | Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure | 000 | 4 | NIH | 7/18/2024 | $478,112 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R21CA280020 | Targeting FGFR4 to overcome chemoresistance in ovarian cancer | 000 | 1 | NIH | 12/5/2023 | $215,284 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R37CA276928 | Aging trajectories and outcomes of older adults with acute myeloid leukemia | 000 | 2 | NIH | 7/1/2024 | $489,655 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01DA060753 | Epigenetic regulation of astrocyte-specific NLRP6 inflammasome and PANoptosis in HIV Tat and methamphetamine-mediated neuroinflammation | 000 | 1 | NIH | 6/25/2024 | $513,978 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | NU50CK000619 | Strengthening Healthcare Infection Prevention and Control and Improving Patient Safety in the United States. | 00 | 3 | CDC | 7/1/2024 | $0 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | NU50CK000619 | Strengthening Healthcare Infection Prevention and Control and Improving Patient Safety in the United States. | 00 | 3 | CDC | 7/1/2024 | $10,000 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U01CA253218 | Pre-analytical variables of bioanalytes affecting the accuracy of PTCL diagnostic and prognostic genetic signatures | 000 | 4 | NIH | 8/20/2024 | $348,939 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | NU50CK000619 | Strengthening Healthcare Infection Prevention and Control and Improving Patient Safety in the United States. | 06 | 2 | CDC | 6/11/2024 | $0 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AA029127 | Sex differences in BNST networks during early abstinence in AUD | 000 | 4 | NIH | 7/22/2024 | $594,780 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01GM143329 | CFX Opus 96 Real-Time PCR System for precision genotyping and phenotyping | 001 | 4 | NIH | 9/5/2024 | $34,465 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01GM143329 | CFX Opus 96 Real-Time PCR System for precision genotyping and phenotyping | 000 | 4 | NIH | 8/30/2024 | $307,000 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | NU50CK000619 | Strengthening Healthcare Infection Prevention and Control and Improving Patient Safety in the United States. | 05 | 2 | CDC | 3/5/2024 | $0 |
|
